Thursday, December 19, 2024
HomeTagsFO2CUS

FO2CUS

Akebia Therapeutics Announces Positive Top-Line Results from Vadadustat Alternative Dosing Study

Akebia Therapeutics, Inc, a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced positive top-line results from...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics